Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway

The leading cause of cancer deaths is lung cancer, non-small cell lung cancer (NSCLC), the most common type of lung cancers, remains a difficult cancer to treat and cure. It is urgent to develop new products to treat NSCLS. Gracillin, extracted from Reineckia carnea, Dioscorea villosa, and other med...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yamei, Liu, Hai, Liu, Xiaoxuan, Xiao, Bang, Zhang, Minhong, Luo, Yaoling, Li, Mingchun, Yang, Jianqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980855/
https://www.ncbi.nlm.nih.gov/pubmed/35392243
http://dx.doi.org/10.3389/fonc.2022.851300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980855/
https://www.ncbi.nlm.nih.gov/pubmed/35392243
http://dx.doi.org/10.3389/fonc.2022.851300

Ejemplares similares